Search Results - I. M. Marusenko
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
RESULTS OF AN OPEN CLINICAL STUDY OF THE EFFICACY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS by I M Marusenko
Published 2009-06-01Objective: To evaluate the efficacy of leflunomide versus methotrexate in patients with rheumatoid arthritis. Subjects and methods. The study included 24 patients receiving leflunomide who underwent the determination of changes in the articular syndrome: the Ritchie index, the number of tender and s...
Get full text
Article -
2
EKSTRAKORPORAL'NYE METODY TERAPII V LEChENII RA by I M Marusenko, E A Shtiina
Published 2002-04-01Get full text
Article -
3
HYPERTHYROIDISM AND ATRIAL FIBRILLATION by I. M. Marusenko, E. G. Petrova
Published 2017-07-01Review on a problem of the development of atrial fibrillation in patients with thyrotoxicosis is presented. Thyrotoxicosis is one of the most frequent endocrine diseases, conceding only to a diabetes mellitus. The most frequent reasons of hyperthyroidism are Graves’ disease and functional thyroid au...
Get full text
Article -
4
The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice by I. M. Marusenko, O. N. Sakovich
Published 2021-06-01The article describes the peculiarities of drug provision for patients with psoriatic arthritis (PsA) in the Republic of Karelia. We present a clinical case of effective treatment with interleukin 17 inhibitor ixekizumab (IXE) in a randomized clinical trial and real clinical practice in a patient wi...
Get full text
Article -
5
Features of diagnosis and treatment of anemic syndrome in patients with rheumatoid arthritis by N V Koryakova, N N Vesikova, I M Marusenko
Published 2009-12-01Features of diagnostics and course of anemic syndrome in rheumatoid arthritis patients Objective. To study features of anemic syndrome in rheumatoid arthritis (RA) pts, to estimate influence of disease modifying anti – rheumatic drug therapy efficacy on the course of anemic syndrome. Material and me...
Get full text
Article -
6
Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis by I. M. Marusenko, N. N. Vezikova, S. N. Kondrichin, N. D. Silvestrov
Published 2019-03-01The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasi...
Get full text
Article -
7
Diabetes mellitus in patients with rheumatoid arthritis in the Republic of Karelia by N. V. Koryakova, I. I. Polskaya, I. M. Marusenko, T. I. Kulagina
Published 2020-05-01Objective: to estimate the incidence of diabetes mellitus (DM) in patients with rheumatoid arthritis (RA) in the Republic of Karelia and to analyze the types of carbohydrate metabolism disorders.Patients and methods. The investigation enrolled 889 patients aged 18 years and older with RA treated in...
Get full text
Article -
8
OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT by I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
Published 2017-09-01Aim. To study the prevalence of metabolic syndrome (MS) and total risk of cardiovascular diseases (CVD) in patients with gout depending on the presence of MS.Material and methods. 56 patients (aged 53.3±10.9 years; men 82%) with verified primary chronic gout [median disease duration 5.7 (2.0-8.5) ye...
Get full text
Article -
9
-
10
Structum (chondroitin sulfate) in treatment of osteoarthritis by O J Varga, V K Ignatjev, N N Vesikova, I M Marusenko
Published 2003-02-01Objective. To assess Structum (chondroitin sulfate) efficacy in treatment of osteoarthritis in Republic of Karelia. Methods. 34 pts with osteoarthritis (mean disease duration 6,44±0,67 years) were included. Functional Leken score (FLS), pain at rest and at walk on visual analog scale (VAS), pts nons...
Get full text
Article -
11
Prevalence of rheumatic diseases TOC \o "1-5" \h \z in Karelia Repablic by N N Vesikova, W K Ignatiev, I M Marusenko, O. Yu. Varga
Published 2003-04-01Цель. Анализ распространенности ревматоидного артрита (РА) и остеоартроза (ОА) в Республике Карелия (РК). Результаты. В 2000 г по сравнению с 1998 и 1999 гг. в РК выявлен рост обшей заболеваемости болезнями костно-мышечной системы. Однако показатели общей заболеваемости были более низкими по сравнен...
Get full text
Article -
12
Rheumatoid arthritis and bacterial infections by N L Prokopjeva, N N Vesikova, I M Marusenko, V A Ryabkov
Published 2008-02-01To study features of bacterial infections course in pts with rheumatoid arthritis (RA) and changes of laboratory measures after focus of infection sanation. Material and methods. 46 pts with definite rheumatoid arthritis were examined at the time of comorbid infection (Cl) detection and after infect...
Get full text
Article -
13
POKAZANIYa K LYuMBRIKANTNOY TERAPII GONARTROZA by I I Vezikova, I M Marusenko, V K Ignat'ev, O Yu Varga
Published 2005-06-01Get full text
Article -
14
ASSOCIATION OF rs4537545 (C>T) ALLELE POLYMORPHISM IN THE IL6R GENE WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS by L. V. Topchieva, I. E. Malysheva, O. V. Balan, I. M. Marusenko, O. Yu. Barysheva
Published 2020-06-01Objective: to analyze the association of the polymorphic marker rs4537545 (C>T) in the IL6R gene with the development of rheumatoid arthritis (RA) in the population of the Republic of Karelia. Subjects and methods. The investigation included 190 samples of DNA extracted from the whole blood o...
Get full text
Article -
15
CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME by I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin
Published 2016-05-01Actuality of cardiovascular diseases today determines the high interest to study pathogenesis of atherosclerosis and to searching new risk factors which could help to optimize primary and secondary prevention. Study the correlation between biomarkers of inflammation and traditional risk factors (TRF...
Get full text
Article -
16
Rheumatoid arthritis in real clinical practice. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-I») project by V. N. Amirdzhanova, E. Yu. Pogozheva, A. E. Karateev, R. R. Samigullina, O. B. Nesmeyanova, A. I. Kulikov, O. V. Antipova, E. V. Kryukova, I. G. Bannikova, I. M. Patrikeeva, A. I. Dubikov, R. G. Kamalova, I. B. Vinogradova, R. G. Mukhina, I. M. Marusenko
Published 2019-05-01Objective: to describe the portrait of a patient with rheumatoid arthritis (RA) in real clinical practice, to assess disease activity from the point of view of a physician and a patient, functional status, quality of life (QOL), and the efficiency of the therapy performed.Patients and methods. The i...
Get full text
Article -
17
THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY) by E. L. Nasonov, E. V. Zonova, O. N. Ivanova, L. A. Knyazeva, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko, O. B. Nesmeyanova, T. V. Plaksina, A. E. Sizikov, D. G. Krechikova, N. A. Petrochenkova, Yu. S. Shapovalova, N. S. Soroka, S. I. Pimanov, A. M. Pristrom, E. V. Kunder, E. V. Chernyaeva, A. V. Eremeeva, R. Ivanov
Published 2016-12-01The article considers the results of an international multicenter randomized clinical trial of the efficacy and safety of the brand-name drug rituximab (MabThera), a monoclonal antibody against CD20 antigen of B cells, and its biosimi-lar drug (Acellbia®) (the BIORA study) in patients with rheumatoi...
Get full text
Article -
18
A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization... by A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina
Published 2020-05-01Janus kinase (JK) inhibitors block the intracellular signaling pathways that are responsible for the synthesis of proinflammatory cytokines and mediators, which in turn cause the activation of pain receptors and central sensitization (CS). It is suggested that JK inhibitors can rapidly eliminate pai...
Get full text
Article -
19
THE RATE OF METABOLIC SYNDROME AND COMORBIDITIES IN PATIENTS WITH GOUT: DATA OF A MULTICENTER TRIAL by V G Barskova, Maksim Sergeyevich Eliseyev, I S Denisov, M E Eliseyeva, O A Belikov, G R Fadiyenko, F S Zharskaya, O P Polkovnikova, A N Kalyagin, M V Sklyanova, E A Shvetsova, L A Knyazeva, I M Marusenko, S E Myasoedova, E A Kozhevnikova, M N Petrova, T A Raskina, M V Koroleva, V V Tyrenko, A A Al-Nuvairakh, A G Khanov
Published 2012-12-01Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (86.2%) men and 314 (13.8%) women, from 12 independe...
Get full text
Article -
20
Results of a non-interventional multicenter observational study on the diagnosis and treatment of patients with axial psoriatic arthritis in rea-world clinical practice in the Russ... by T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. А. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov
Published 2024-12-01Objective: The aim of the NiSaXPA study is to evaluate the quality of diagnosing, socio-demographic characteristics and treatment tactics of patients with axial psoriatic arthritis (axPsA) in real-world clinical practice in the Russian Federation.Material and methods. The study involved 600 patients...
Get full text
Article